Publication date: Dec 01, 2026
Women are disproportionately diagnosed with symptom-based conditions, notably post-COVID condition (PCC). In Sweden, as of February 2022, 2. 3% of PCR-verified female COVID-19 cases versus 1. 6% of male cases had a PCC diagnosis. Post-viral fatigue syndrome (PVFS) and exhaustion disorder (ED), a common and relevant diagnosis in Sweden, share substantial symptom overlap with PCC. To quantify the association between pre-pandemic, symptom-based primary-care visits and subsequent PCC, PVFS, and ED among adult women, adjusting for risk factors for severe COVID-19. We conducted a registry-based prospective cohort study of 208,050 women from the Swedish Medical Birth Register, linked to primary-care data and national sociodemographic registers. The exposure was the frequency of visits for predefined symptom-based conditions during 2015-2019. Adjusted odds ratios (ORs) for diagnoses in 2020-2024 were estimated using logistic regression controlling for BMI, education, age, and region of birth. Across 2,431,182 primary-care physician visits, 19% were symptom-based. Women with >8 such visits had higher odds of all three outcomes: PCC (OR 5. 45, 95% CI 4. 43-6. 71), PVFS (OR 7. 71, 95% CI 5. 97-9. 96), and ED (OR 5. 32, 95% CI 4. 84-5. 85). Pre-pandemic BMI and education were not associated with PCC or PVFS but showed some association with ED. Still, 17% of women with PCC had no recorded symptom-based visits before the pandemic. Pre-pandemic symptom-based primary-care visits were strongly associated with higher risk of PCC, PVFS, and ED in a dose-dependent way, but modest discrimination underscores heterogeneous individual risk. Patterns suggest other influences alongside biological susceptibility.
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | post-COVID condition |
| disease | MESH | fatigue |
| disease | MESH | syndrome |
| drug | DRUGBANK | Factor IX Complex (Human) |
| disease | MESH | PCC |
| disease | MESH | COVID-19 |
| disease | MESH | Fatigue Syndrome Chronic |